Sage Therapeutics, Inc.
SAGEDelisted Jul 31, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001597553
Sage Therapeutics, Inc. was delisted on Jul 31, 2025; its insiders filed their last Form 4 on Jul 31, 2025; 192 institutions reported holding it in 13F filings for Q2 2025, worth $445.6M in total; no superinvestor held it.
13F holders, Q2 2021
Institutional positions in Sage Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 257
- −5 vs. Q1 2021
- Shares held
- 50.7M
- −2.23M (−4.2%) vs. Q1 2021
- Total value
- $2.88B
- −$1.08B (−27.3%) vs. Q1 2021
- New holders
- 41
- 101 more added
- Sold out
- 46
- 73 more reduced
1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SAGE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $9 |
| Q1 2026 | 1 | $9 |
| Q4 2025 | 2 | $460.0K |
| Q3 2025 | 5 | $494.0K |
| Q2 2025 | 192 | $445.6M |
| Q1 2025 | 198 | $411.4M |
| Q4 2024 | 177 | $278.2M |
| Q3 2024 | 177 | $373.7M |
| Q2 2024 | 196 | $581.3M |
| Q1 2024 | 206 | $1.10B |
| Q4 2023 | 202 | $1.22B |
| Q3 2023 | 195 | $1.21B |
| Q2 2023 | 225 | $2.54B |
| Q1 2023 | 214 | $2.22B |
| Q4 2022 | 207 | $1.97B |
| Q3 2022 | 201 | $2.02B |
| Q2 2022 | 211 | $1.65B |
| Q1 2022 | 212 | $1.65B |
| Q4 2021 | 217 | $2.14B |
| Q3 2021 | 227 | $2.17B |
| Q2 2021 | 257 | $2.88B |
| Q1 2021 | 263 | $3.97B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Sage Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sowell Financial Services LLC | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Meridian Wealth Partners, LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Amundi Asset Management US, Inc. | – | – | – | – | Not filed |